The Vascularity Changes of Scars With Laser Therapy

NCT ID: NCT03986346

Last Updated: 2020-03-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

45 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-05-31

Study Completion Date

2020-02-27

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to explore the effects of pulsed dye laser on managing scar vascularity and thickness.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The pulsed dye laser is increasingly used in clinical settings to manage scars and shows promising outcomes.The pulsed dye laser targets at micro-vascular structures in scar tissues. This study aims to explore the vascularity changes in scars with pulsed dye laser during the scar formation process.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypertrophic Scar

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Laser group

Participants in this group receive pulsed dye laser to treat the scar.

Group Type EXPERIMENTAL

pulsed dye laser

Intervention Type DEVICE

The scar will receive PDL 585 nm using a 7 mm spot size. First treatment will be within 1 year post injury.

standardized care

Intervention Type OTHER

the scar will receive standardized care such as scar massage.

Control group

Participants in this group receive standardized care.

Group Type ACTIVE_COMPARATOR

standardized care

Intervention Type OTHER

the scar will receive standardized care such as scar massage.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

pulsed dye laser

The scar will receive PDL 585 nm using a 7 mm spot size. First treatment will be within 1 year post injury.

Intervention Type DEVICE

standardized care

the scar will receive standardized care such as scar massage.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* scars caused by burn injury or related trauma;
* wound healing days over 3 weeks;
* days post injury less than 1 year;
* ability and willingness to comply with all the treatment and assessment procedures.

Exclusion Criteria

* history of steroid injection or graft surgery;
* history of keloid scarring;
* open wound or active infection;
* conditions that affect wound healing, such as diabetes mellitus.
Minimum Eligible Age

16 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Chinese University of Hong Kong

OTHER

Sponsor Role collaborator

Southwest Hospital, China

OTHER

Sponsor Role collaborator

The Hong Kong Polytechnic University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Cecilia Li-tsang

Role: PRINCIPAL_INVESTIGATOR

The Hong Kong Polytechnic University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Southwest Hospital

Chongqing, , China

Site Status

Prince of Wales Hospital

Hong Kong, , Hong Kong

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China Hong Kong

References

Explore related publications, articles, or registry entries linked to this study.

Deng H, Li-Tsang CWP. Measurement of vascularity in the scar: A systematic review. Burns. 2019 Sep;45(6):1253-1265. doi: 10.1016/j.burns.2018.10.026. Epub 2018 Dec 10.

Reference Type BACKGROUND
PMID: 30545695 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

HSEARS20190402002

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.